Inhibition	0	10	O
of	11	13	O
PDGF	14	18	B-Gene_or_gene_product
-	18	19	O
stimulated	19	29	O
and	30	33	O
matrix	34	40	B-Cellular_component
-	40	41	O
mediated	41	49	O
proliferation	50	63	O
of	64	66	O
human	67	72	B-Organism
vascular	73	81	B-Cell
smooth	82	88	I-Cell
muscle	89	95	I-Cell
cells	96	101	I-Cell
by	102	104	O
SPARC	105	110	B-Gene_or_gene_product
is	111	113	O
independent	114	125	O
of	126	128	O
changes	129	136	O
in	137	139	O
cell	140	144	B-Cell
shape	145	150	O
or	151	153	O
cyclin	154	160	B-Drug_or_compound
-	160	161	I-Drug_or_compound
dependent	161	170	I-Drug_or_compound
kinase	171	177	I-Drug_or_compound
inhibitors	178	188	I-Drug_or_compound
.	188	189	O

Interactions	191	203	O
among	204	209	O
growth	210	216	O
factors	217	224	O
,	224	225	O
cells	226	231	B-Cell
,	231	232	O
and	233	236	O
extracellular	237	250	B-Cellular_component
matrix	251	257	I-Cellular_component
regulate	258	266	O
proliferation	267	280	O
during	281	287	O
normal	288	294	O
development	295	306	O
and	307	310	O
in	311	313	O
pathologies	314	325	O
such	326	330	O
as	331	333	O
atherosclerosis	334	349	O
.	349	350	O

SPARC	351	356	B-Gene_or_gene_product
(	357	358	O
secreted	358	366	B-Gene_or_gene_product
protein	367	374	I-Gene_or_gene_product
,	374	375	I-Gene_or_gene_product
acidic	376	382	I-Gene_or_gene_product
,	382	383	I-Gene_or_gene_product
and	384	387	I-Gene_or_gene_product
rich	388	392	I-Gene_or_gene_product
in	393	395	I-Gene_or_gene_product
cysteine	396	404	I-Gene_or_gene_product
)	404	405	O
is	406	408	O
a	409	410	O
matrix	411	417	B-Cellular_component
-	417	418	O
associated	418	428	O
glycoprotein	429	441	O
that	442	446	O
modulates	447	456	O
the	457	460	O
adhesion	461	469	O
and	470	473	O
proliferation	474	487	O
of	488	490	O
vascular	491	499	B-Cell
cells	500	505	I-Cell
.	505	506	O

In	507	509	O
this	510	514	O
study	515	520	O
,	520	521	O
we	522	524	O
demonstrate	525	536	O
that	537	541	O
SPARC	542	547	B-Gene_or_gene_product
inhibits	548	556	O
human	557	562	B-Organism
arterial	563	571	B-Cell
smooth	572	578	I-Cell
muscle	579	585	I-Cell
cell	586	590	I-Cell
proliferation	591	604	O
stimulated	605	615	O
by	616	618	O
platelet	619	627	B-Gene_or_gene_product
-	627	628	I-Gene_or_gene_product
derived	628	635	I-Gene_or_gene_product
growth	636	642	I-Gene_or_gene_product
factor	643	649	I-Gene_or_gene_product
or	650	652	O
by	653	655	O
adhesion	656	664	O
to	665	667	O
monomeric	668	677	B-Gene_or_gene_product
type	678	682	I-Gene_or_gene_product
I	683	684	I-Gene_or_gene_product
collagen	685	693	I-Gene_or_gene_product
.	693	694	O

Binding	695	702	O
studies	703	710	O
with	711	715	O
SPARC	716	721	B-Gene_or_gene_product
and	722	725	O
SPARC	726	731	B-Gene_or_gene_product
peptides	732	740	I-Gene_or_gene_product
indicate	741	749	O
specific	750	758	O
and	759	762	O
saturable	763	772	O
interaction	773	784	O
with	785	789	O
smooth	790	796	B-Cell
muscle	797	803	I-Cell
cells	804	809	I-Cell
that	810	814	O
involves	815	823	O
the	824	827	O
C	828	829	B-Protein_domain_or_region
-	829	830	I-Protein_domain_or_region
terminal	830	838	I-Protein_domain_or_region
Ca2	839	842	I-Protein_domain_or_region
+	842	843	I-Protein_domain_or_region
-	843	844	I-Protein_domain_or_region
binding	844	851	I-Protein_domain_or_region
region	852	858	I-Protein_domain_or_region
of	859	861	O
the	862	865	O
protein	866	873	O
.	873	874	O

We	875	877	O
also	878	882	O
report	883	889	O
that	890	894	O
SPARC	895	900	B-Gene_or_gene_product
arrests	901	908	O
monomeric	909	918	O
collagen	919	927	B-Gene_or_gene_product
-	927	928	O
supported	928	937	O
smooth	938	944	B-Cell
muscle	945	951	I-Cell
cell	952	956	I-Cell
proliferation	957	970	O
in	971	973	O
the	974	977	O
late	978	982	O
G1	983	985	O
-	985	986	O
phase	986	991	O
of	992	994	O
the	995	998	O
cell	999	1003	B-Cell
cycle	1004	1009	O
in	1010	1012	O
the	1013	1016	O
absence	1017	1024	O
of	1025	1027	O
an	1028	1030	O
effect	1031	1037	O
on	1038	1040	O
cell	1041	1045	B-Cell
shape	1046	1051	O
or	1052	1054	O
on	1055	1057	O
levels	1058	1064	O
of	1065	1067	O
cyclin	1068	1074	B-Drug_or_compound
-	1074	1075	I-Drug_or_compound
dependent	1075	1084	I-Drug_or_compound
kinase	1085	1091	I-Drug_or_compound
inhibitors	1092	1102	I-Drug_or_compound
.	1102	1103	O

Cyclin	1104	1110	B-Gene_or_gene_product
-	1110	1111	I-Gene_or_gene_product
dependent	1111	1120	I-Gene_or_gene_product
kinase	1121	1127	I-Gene_or_gene_product
-	1127	1128	I-Gene_or_gene_product
2	1128	1129	I-Gene_or_gene_product
activity	1130	1138	O
,	1138	1139	O
p107	1140	1144	B-Gene_or_gene_product
and	1145	1148	O
cyclin	1149	1155	B-Gene_or_gene_product
A	1156	1157	I-Gene_or_gene_product
levels	1158	1164	O
,	1164	1165	O
and	1166	1169	O
retinoblastoma	1170	1184	B-Gene_or_gene_product
protein	1185	1192	I-Gene_or_gene_product
phosphorylation	1193	1208	O
are	1209	1212	O
markedly	1213	1221	O
reduced	1222	1229	O
in	1230	1232	O
response	1233	1241	O
to	1242	1244	O
the	1245	1248	O
addition	1249	1257	O
of	1258	1260	O
exogenous	1261	1270	O
SPARC	1271	1276	B-Gene_or_gene_product
and	1277	1280	O
/	1280	1281	O
or	1281	1283	O
peptides	1284	1292	O
derived	1293	1300	O
from	1301	1305	O
specific	1306	1314	O
domains	1315	1322	O
of	1323	1325	O
SPARC	1326	1331	B-Gene_or_gene_product
.	1331	1332	O

Thus	1333	1337	O
,	1337	1338	O
SPARC	1339	1344	B-Gene_or_gene_product
,	1344	1345	O
previously	1346	1356	O
characterized	1357	1370	O
as	1371	1373	O
an	1374	1376	O
inhibitor	1377	1386	O
of	1387	1389	O
platelet	1390	1398	B-Gene_or_gene_product
-	1398	1399	I-Gene_or_gene_product
derived	1399	1406	I-Gene_or_gene_product
growth	1407	1413	I-Gene_or_gene_product
factor	1414	1420	I-Gene_or_gene_product
binding	1421	1428	O
to	1429	1431	O
its	1432	1435	O
receptor	1436	1444	O
,	1444	1445	O
also	1446	1450	O
antagonizes	1451	1462	O
smooth	1463	1469	B-Cell
muscle	1470	1476	I-Cell
cell	1477	1481	I-Cell
proliferation	1482	1495	O
mediated	1496	1504	O
by	1505	1507	O
monomeric	1508	1517	O
collagen	1518	1526	B-Gene_or_gene_product
at	1527	1529	O
the	1530	1533	O
level	1534	1539	O
of	1540	1542	O
cyclin	1543	1549	B-Gene_or_gene_product
-	1549	1550	I-Gene_or_gene_product
dependent	1550	1559	I-Gene_or_gene_product
kinase	1560	1566	I-Gene_or_gene_product
-	1566	1567	I-Gene_or_gene_product
2	1567	1568	I-Gene_or_gene_product
activity	1569	1577	O
.	1577	1578	O

